The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 1 , Pages 206-214, July 2009

The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: A randomized controlled trial

  • Massimo Caputo, MD

      Affiliations

    • Bristol Heart Institute, Bristol, United Kingdom
    • Corresponding Author InformationAddress for reprints: M. Caputo, MD, Bristol Heart Institute, University of Bristol, Bristol Royal Children's Hospital, Bristol, BS2 8HW, United Kingdom.
  • ,
  • Amir Mokhtari, MRCS

      Affiliations

    • Bristol Royal Hospital for Children, Bristol, United Kingdom
  • ,
  • Chris A. Rogers, PhD

      Affiliations

    • Bristol Heart Institute, Bristol, United Kingdom
  • ,
  • Nayia Panayiotou, MSc

      Affiliations

    • Bristol Heart Institute, Bristol, United Kingdom
  • ,
  • Qiang Chen, PhD

      Affiliations

    • Bristol Royal Hospital for Children, Bristol, United Kingdom
  • ,
  • Mohamed T. Ghorbel, PhD

      Affiliations

    • Bristol Heart Institute, Bristol, United Kingdom
  • ,
  • Gianni D. Angelini, FRCS

      Affiliations

    • Bristol Heart Institute, Bristol, United Kingdom
  • ,
  • Andrew J. Parry, FRCS

      Affiliations

    • Bristol Royal Hospital for Children, Bristol, United Kingdom

Received 19 September 2008; received in revised form 21 November 2008; accepted 25 December 2008. published online 23 February 2009.

Objectives

This study investigates the effects of controlled reoxygenation cardiopulmonary bypass on oxidative stress, inflammatory response, and organ function in children undergoing repair of cyanotic congenital heart defects.

Methods

Sixty-seven cyanotic patients (median age 15 months, interquartile range 6–49 months) undergoing corrective cardiac surgery were randomized to receive either controlled normoxic (50–0 mm Hg; n = 35) or hyperoxic (150–180 mm Hg; n = 32) cardiopulmonary bypass. Troponin I and 8-isoprostane, C3a, interleukins 6, 8, and 10, cortisol, protein S100, and alpha-glutamate transferase were measured preoperatively and 10 and 30 minutes after starting bypass, on removal of the aortic crossclamp, and 12 and 24 hours thereafter.

Results

Overall, troponin I and 8-isoprostane levels were lower in the controlled normoxic group (−29%, 95% CI −48% to −3%, P = .03, and −26%, 95% CI −44% to −2%, P = .03, respectively). Protein S100 release was also lower in the normoxic group 10 minutes after starting bypass (−26%, 95% CI −40% to −9%, P = .005) and 10 minutes after aortic crossclamp removal (−23%, 95% CI −38% to −3%, P = .02, respectively), but similar at other time points in the two groups (P ≥ .17). The alpha-glutamate transferase release was significantly lower in the normoxic group 10 minutes after aortic crossclamp removal (−28%, 95% CI −44% to −9%, P = .006, respectively) but was similar at other times (P ≥ .11). Release of C3a, interleukins 6, 8, and 10, and cortisol was similar in the two groups throughout (P ≥ .15).

Conclusion

Controlled reoxygenation on starting cardiopulmonary bypass is associated with reduced myocardial damage, oxidative stress, and cerebral and hepatic injury compared with hyperoxic bypaass and similar whole body inflammatory and stress response in cyanotic children undergoing open cardiac surgery.

CTSNet classification: 21, 31

Abbreviations and Acronyms: άGT, alpha-glutathione S-transferase, C3a, complement activation, CI, confidence interval, CPB, cardiopulmonary bypass, EIA, enzyme immunosorbent assay, Fio2, forced expiratory volume in 1 second

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The BUPA Foundation, National Heart Research Fund, Garfield Weston Trust, and the British Heart Foundation supported this work.

 All participants in this study have seen and approved the final version and have no conflicts of interest to disclose.

PII: S0022-5223(09)00018-X

doi:10.1016/j.jtcvs.2008.12.028

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 1 , Pages 206-214, July 2009